Rafael Hernani

1.5k total citations
32 papers, 343 citations indexed

About

Rafael Hernani is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, Rafael Hernani has authored 32 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Epidemiology and 10 papers in Hematology. Recurrent topics in Rafael Hernani's work include CAR-T cell therapy research (13 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Respiratory viral infections research (6 papers). Rafael Hernani is often cited by papers focused on CAR-T cell therapy research (13 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Respiratory viral infections research (6 papers). Rafael Hernani collaborates with scholars based in Spain, Germany and France. Rafael Hernani's co-authors include Carlos Solano, Ariadna Pérez, José Luís Piñana, Manuel Guerreiro, David Navarro, Juan Carlos Hernández‐Boluda, Juan Montoro, Mi Kwon, Eliseo Albert and Estela Giménez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Rafael Hernani

26 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rafael Hernani Spain	10	243	100	91	56	56	32	343
Chu Ri Shin United States	6	114 0.5×	68 0.7×	76 0.8×	139 2.5×	29 0.5×	13	299
Chan Liao China	10	164 0.7×	90 0.9×	137 1.5×	44 0.8×	13 0.2×	29	416
Eleftheria Kampouri Switzerland	13	196 0.8×	121 1.2×	29 0.3×	68 1.2×	19 0.3×	42	439
J. Joseph Melenhorst United States	5	161 0.7×	126 1.3×	126 1.4×	80 1.4×	13 0.2×	9	374
Ming‐Celine Dubosq Australia	5	233 1.0×	261 2.6×	52 0.6×	123 2.2×	12 0.2×	5	403
Jacqueline M. Keirnan United States	5	463 1.9×	282 2.8×	50 0.5×	213 3.8×	24 0.4×	6	628
Colby R. Maldini United States	9	305 1.3×	46 0.5×	31 0.3×	115 2.1×	30 0.5×	16	511
John A. Ligon United States	10	105 0.4×	23 0.2×	14 0.2×	28 0.5×	22 0.4×	32	215
Patricia Graef Germany	5	225 0.9×	89 0.9×	101 1.1×	69 1.2×	8 0.1×	5	490
Jan Dirks Germany	14	164 0.7×	314 3.1×	33 0.4×	12 0.2×	44 0.8×	23	566

Countries citing papers authored by Rafael Hernani

Since Specialization

Citations

This map shows the geographic impact of Rafael Hernani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Hernani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Hernani more than expected).

Fields of papers citing papers by Rafael Hernani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Hernani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Hernani. The network helps show where Rafael Hernani may publish in the future.

Co-authorship network of co-authors of Rafael Hernani

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Hernani. A scholar is included among the top collaborators of Rafael Hernani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Hernani. Rafael Hernani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez, Ariadna, Juan Montoro, Rafael Hernani, et al.. (2025). Assessment of the Immunodeficiency Scoring Index for Predicting Outcomes After Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients. Transplantation and Cellular Therapy. 31(5). 325.e1–325.e17. 2 indexed citations

Mora, Elvira, Rafael Hernani, José Cervera, et al.. (2025). Rapid Screening and Monitoring of UBA1 Mutations in VEXAS Syndrome. Journal of Molecular Diagnostics. 27(6). 431–437.

Camacho-Arteaga, Lina, Gloria Iacoboni, Mi Kwon, et al.. (2025). Late Adverse Events After Chimeric Antigen Receptor T-Cell Therapy for Patients With Aggressive B-Cell Non-Hodgkin Lymphoma. JAMA Network Open. 8(2). e2461683–e2461683.

Bastos‐Oreiro, Mariana, Gloria Iacoboni, Vı́ctor Navarro, et al.. (2025). Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. HemaSphere. 9(2). e70077–e70077. 1 indexed citations

Esquirol, Albert, María Pascual, Juan Montoro, et al.. (2024). Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil. Transplantation and Cellular Therapy. 30(10). 1025.e1–1025.e14.

Piñana, José Luís, Juan Antonio Carbonell‐Asins, María Dolores Gómez‐Ruiz, et al.. (2024). Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant?. Clinical Infectious Diseases. 81(3). 570–580. 3 indexed citations

Pérez, Ariadna, Juan Montoro, Rafael Hernani, et al.. (2024). Are any specific respiratory viruses more severe than others in recipients of allogeneic stem cell transplantation? A focus on lower respiratory tract disease. Bone Marrow Transplantation. 59(8). 1118–1126. 4 indexed citations

Albert, Eliseo, Estela Giménez, Rafael Hernani, et al.. (2024). Torque Teno Virus DNA Load in Blood as an Immune Status Biomarker in Adult Hematological Patients: The State of the Art and Future Prospects. Viruses. 16(3). 459–459. 6 indexed citations

Sánchez‐Pina, José María, Lucía López‐Corral, Anabelle Chinea, et al.. (2024). Treatment with Siltuximab for Short Term Complications after Chimeric Antigen Receptor T-Cell Therapy: A Multicenter Retrospective Analysis. Blood. 144(Supplement 1). 7220–7220.

10.

Pérez, Ariadna, Juan Montoro, Manuel Guerreiro, et al.. (2024). Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy. Infection. 52(5). 1941–1952. 6 indexed citations

11.

Giménez, Estela, Eliseo Albert, Rafael Hernani, et al.. (2024). Performance of the Roche Elecsys® IGRA SARS-CoV-2 test for the detection and quantification of virus-reactive T cells in COVID-19-vaccinated immunosuppressed patients and healthy subjects. European Journal of Clinical Microbiology & Infectious Diseases. 43(7). 1427–1436.

12.

Hernani, Rafael, et al.. (2023). #5525 NEPHROTOXICITY OF CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY: ACUTE KIDNEY INJURY AND ELECTROLYTE DISORDERS. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations

13.

Rampotas, Alexandros, Katja Sockel, Fotios Panitsas, et al.. (2023). Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study. Transplantation and Cellular Therapy. 29(11). 687.e1–687.e7. 2 indexed citations

14.

Giménez, Estela, Manuel Guerreiro, Ignacio Torres, et al.. (2023). Features of cytomegalovirus DNAemia and virus‐specific T‐cell responses in allogeneic hematopoietic stem‐cell transplant recipients during prophylaxis with letermovir. Transplant Infectious Disease. 25(2). e14021–e14021. 8 indexed citations

15.

Hernani, Rafael, et al.. (2022). Toxicities following CAR-T therapy for hematological malignancies. Cancer Treatment Reviews. 111. 102479–102479. 30 indexed citations

16.

Esquirol, Albert, María Pascual, Mi Kwon, et al.. (2021). Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide. Bone Marrow Transplantation. 56(10). 2432–2444. 42 indexed citations

17.

Hernani, Rafael, José Luís Piñana, Ariadna Pérez, et al.. (2021). Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis. SHILAP Revista de lepidopterología. 2(2). 236–248. 5 indexed citations

18.

Hernani, Rafael, Asunción Sancho, Paula Amat, et al.. (2021). CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review. Current Research in Translational Medicine. 69(4). 103304–103304. 15 indexed citations

19.

Huntley, Dixie, Estela Giménez, Juan Carlos Hernández‐Boluda, et al.. (2020). Features of Cytomegalovirus DNAemia Blips in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Implications for Optimization of Preemptive Antiviral Therapy Strategies. Biology of Blood and Marrow Transplantation. 26(5). 972–977. 14 indexed citations

20.

Piñana, José Luís, Ariadna Pérez, Juan Montoro, et al.. (2019). The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey. Bone Marrow Transplantation. 55(2). 431–440. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact